Form 8-K - Current report:
SEC Accession No. 0001185185-25-001428
Filing Date
2025-10-14
Accepted
2025-10-10 19:49:19
Documents
15
Period of Report
2025-10-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc8k101025.htm   iXBRL 8-K 38425
2 EXHIBIT 99.1 igcex99-1.htm EX-99.1 6606
3 GRAPHIC image_001.jpg GRAPHIC 5410
7 GRAPHIC ex99-1_001.jpg GRAPHIC 22157
  Complete submission text file 0001185185-25-001428.txt   258644

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE igc-20251010.xsd EX-101.SCH 3010
5 XBRL LABEL FILE igc-20251010_lab.xml EX-101.LAB 34235
6 XBRL PRESENTATION FILE igc-20251010_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT igc8k101025_htm.xml XML 3542
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 251389021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)